MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 593068 | Name: Sodium deoxycholate
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sodium deoxycholate is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.

Chemical Structure

Sodium deoxycholate
Sodium deoxycholate
CAS#302-95-4

Theoretical Analysis

MedKoo Cat#: 593068

Name: Sodium deoxycholate

CAS#: 302-95-4

Chemical Formula: C24H39NaO4

Exact Mass: 414.2746

Molecular Weight: 414.56

Elemental Analysis: C, 69.53; H, 9.48; Na, 5.55; O, 15.44

Price and Availability

Size Price Availability Quantity
25g USD 250.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Sodium deoxycholate
IUPAC/Chemical Name
3,12-Dihydroxy-cholan-24-oic acid monosodium salt, (3-alpha,5-beta,12-alpha)- (9CI)
InChi Key
FHHPUSMSKHSNKW-SMOYURAASA-M
InChi Code
InChI=1S/C24H40O4.Na/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3;/h14-21,25-26H,4-13H2,1-3H3,(H,27,28);/q;+1/p-1/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-;/m1./s1
SMILES Code
C[C@H](CCC([O-])=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 414.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Andrade C. Adverse Pregnancy Outcomes Associated With Gestational Exposure to Antiepileptic Drugs. J Clin Psychiatry. 2018 Jul 31;79(4). pii: 18f12467. doi: 10.4088/JCP.18f12467. PubMed PMID: 30085439. 2: Tian Z, Dong C, Zhang K, Chang L, Hashimoto K. Lack of antidepressant effects of low-voltage-sensitive T-type calcium channel blocker ethosuximide in a chronic social defeat stress model: Comparison with (R)-ketamine. Int J Neuropsychopharmacol. 2018 Aug 6. doi: 10.1093/ijnp/pyy072. [Epub ahead of print] PubMed PMID: 30085247. 3: Smith KM, Youssef PE, Wirrell EC, Nickels KC, Payne ET, Britton JW, Shin C, Cascino GD, Patterson MC, Wong-Kisiel LC. Jeavons Syndrome: Clinical Features and Response to Treatment. Pediatr Neurol. 2018 Jul 10. pii: S0887-8994(18)30351-5. doi: 10.1016/j.pediatrneurol.2018.06.001. [Epub ahead of print] PubMed PMID: 30082241. 4: de Baat C, Zweers PGMA, Vissink A. [Medicaments and oral healthcare. Proliferation of the gingiva]. Ned Tijdschr Tandheelkd. 2018 Jul;125(7-8):397-402. doi: 10.5177/ntvt.2018.07/08.18123. Dutch. PubMed PMID: 30015815. 5: Osiecka N, Gałązka M, Marzec M, Zając W, Massalska-Arodź M. Molecular dynamic in ethosuximide glass forming pharmaceutical as studied by dielectric relaxation spectroscopy. J Pharm Sci. 2018 Jul 12. pii: S0022-3549(18)30397-6. doi: 10.1016/j.xphs.2018.06.030. [Epub ahead of print] PubMed PMID: 30009796. 6: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501219/ PubMed PMID: 30000278. 7: Yoshizawa K, Arai N, Suzuki Y, Nakamura T, Takeuchi K, Sakamoto R, Masuda R. Evaluation of the antinociceptive activities of several sodium channel blockers using veratrine test in mice. Synapse. 2018 Jul 11. doi: 10.1002/syn.22056. [Epub ahead of print] PubMed PMID: 29993143. 8: Patsalos PN, Spencer EP, Berry DJ. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. Ther Drug Monit. 2018 Jun 26. doi: 10.1097/FTD.0000000000000546. [Epub ahead of print] PubMed PMID: 29957667. 9: Kunisawa N, Shimizu S, Kato M, Iha HA, Iwai C, Hashimura M, Ogawa M, Kawaji S, Kawakita K, Abe K, Ohno Y. Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents. J Pharmacol Sci. 2018 Jun;137(2):162-169. doi: 10.1016/j.jphs.2018.05.007. Epub 2018 Jun 7. PubMed PMID: 29945769. 10: Wong SQ, Pontifex MG, Phelan MM, Pidathala C, Kraemer BC, Barclay JW, Berry NG, O'Neill PM, Burgoyne RD, Morgan A. α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy. Neurobiol Dis. 2018 Oct;118:40-54. doi: 10.1016/j.nbd.2018.06.013. Epub 2018 Jun 22. PubMed PMID: 29940336. 11: Stewart E, Catroppa C, Gill D, Webster R, Lawson J, Mandalis A, Sabaz M, Barton B, Lah S. Theory of Mind and social competence in children and adolescents with genetic generalised epilepsy (GGE): Relationships to epilepsy severity and anti-epileptic drugs. Seizure. 2018 Aug;60:96-104. doi: 10.1016/j.seizure.2018.06.015. Epub 2018 Jun 18. PubMed PMID: 29933178. 12: Masicampo ML, Shan HQ, Xu V, Speagle M, Godwin DW. Selective Blockade of T-Type Ca2+ Channels is Protective Against Alcohol-Withdrawal Induced Seizure and Mortality. Alcohol Alcohol. 2018 Jun 15. doi: 10.1093/alcalc/agy042. [Epub ahead of print] PubMed PMID: 29912275. 13: Pawluski JL, Kuchenbuch M, Hadjadj S, Dieuset G, Costet N, Vercueil L, Biraben A, Martin B. Long-term negative impact of an inappropriate first antiepileptic medication on the efficacy of a second antiepileptic medication in mice. Epilepsia. 2018 Jul;59(7):e109-e113. doi: 10.1111/epi.14454. Epub 2018 Jun 14. PubMed PMID: 29901235. 14: Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13. PubMed PMID: 29898971. 15: Arvio M, Sauna-Aho O, Nyrke T, Bjelogrlic-Laakso N. Intellectual disability in patients with epilepsy with eyelid myoclonias. SAGE Open Med Case Rep. 2018 May 21;6:2050313X18777951. doi: 10.1177/2050313X18777951. eCollection 2018. PubMed PMID: 29844915; PubMed Central PMCID: PMC5966842. 16: Campos MSA, Ayres LR, Morelo MRS, Carizio FAM, Pereira LRL. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018 May 9. doi: 10.1007/s11096-018-0641-9. [Epub ahead of print] PubMed PMID: 29744790. 17: Orczyk JJ, Garraghty PE. The effects of ethosuximide on aversive instrumental learning in adult rats. Epilepsy Behav. 2018 Jul;84:1-9. doi: 10.1016/j.yebeh.2018.03.038. Epub 2018 May 3. PubMed PMID: 29730499. 18: Tenney JR, Kadis DS, Agler W, Rozhkov L, Altaye M, Xiang J, Vannest J, Glauser TA. Ictal connectivity in childhood absence epilepsy: Associations with outcome. Epilepsia. 2018 May;59(5):971-981. doi: 10.1111/epi.14067. Epub 2018 Apr 6. PubMed PMID: 29633248. 19: Kerckhove N, Pereira B, Soriot-Thomas S, Alchaar H, Deleens R, Hieng VS, Serra E, Lanteri-Minet M, Arcagni P, Picard P, Lefebvre-Kuntz D, Maindet C, Mick G, Balp L, Lucas C, Creach C, Letellier M, Martinez V, Navez M, Delbrouck D, Kuhn E, Piquet E, Bozzolo E, Brosse C, Lietar B, Marcaillou F, Hamdani A, Leroux-Bromberg N, Perier Y, Vergne-Salle P, Gov C, Delage N, Gillet D, Romettino S, Richard D, Mallet C, Bernard L, Lambert C, Dubray C, Duale C, Eschalier A. Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. Eur J Pain. 2018 Aug;22(7):1321-1330. doi: 10.1002/ejp.1221. Epub 2018 Apr 18. PubMed PMID: 29577519. 20: Crettenand M, Rossetti AO, Buclin T, Winterfeld U. [Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]. Nervenarzt. 2018 Aug;89(8):913-921. doi: 10.1007/s00115-018-0496-2. German. PubMed PMID: 29487964.

View History

SK-575

SK-575

Featured